HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Kaposi's sarcoma treated with topical alitretinoin].

Abstract
Kaposi's sarcoma is a multifocal neoplastic process with four clinical variants, all of them induced by human herpes virus 8. Currently there is no treatment of choice and it depends on the extension and location of the lesions as well as on the clinical type of the disease. Alitretinoin gel 0.1 % is approved for the treatment of cutaneous lesions of AIDS-associated Kaposi's sarcoma. The majority of its side effects appear at the site of application and can lead to therapy withdrawal. We report a case of Kaposi's sarcoma treated with topical alitretinoin that had a favourable evolution in spite of an intense local reaction.
AuthorsA González de Arriba, S Pérez-Gala, R Goiriz-Valdés, L Ríos-Buceta, A García-Díez
JournalActas dermo-sifiliograficas (Actas Dermosifiliogr) 2007 Jan-Feb Vol. 98 Issue 1 Pg. 50-3 ISSN: 0001-7310 [Print] Spain
Vernacular TitleSarcoma de Kaposi clásico tratado con alitretinoína tópica.
PMID17374335 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Alitretinoin
  • Tretinoin
Topics
  • Administration, Topical
  • Aged, 80 and over
  • Alitretinoin
  • Antineoplastic Agents (administration & dosage)
  • Female
  • Humans
  • Sarcoma, Kaposi (drug therapy)
  • Skin Neoplasms (drug therapy)
  • Tretinoin (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: